Hypokalemia correlated with arterial stiffness but not microvascular endothelial function in patients with primary aldosteronism

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 16, Issue 2, 2015, Pages 353-359

  Chang, Yi Yao ^a   Chen, Aaron ^b   Chen, Ying Hsien ^c   Hung, Chi Sheng ^c   Wu, Vin Cent ^c   Wu, Xue Ming ^d   Lin, Yen Hung ^c   Ho, Yi Lwun ^c   Wu, Kwan Dun ^c  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b Woodhull Hospital   (United States)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d TAO YUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

arterial stiffness; augmentation index; hypokalemia; peripheral arterial tonometry; Primary aldosteronism

Indexed keywords

POTASSIUM;

ADULT; ARTERIAL STIFFNESS; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL FUNCTION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPEREMIA; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL ARTERIAL TONOMETRY; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; PROSPECTIVE STUDY; COMPLICATION; HYPERALDOSTERONISM; MANOMETRY; MICROVASCULATURE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; VASCULAR ENDOTHELIUM;

ADULT; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPOKALEMIA; MALE; MANOMETRY; MICROVESSELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; VASCULAR STIFFNESS;

EID: 84930889560     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320314524996     Document Type: Article

References (40)

1. De Rosa M, Galatola M, Quaglietta L, et al. Alu-mediated genomic deletion of the serine/threonine protein kinase 11 (STK11) gene in Peutz-Jeghers syndrome. Gastroenterology. 2010 ; 138: 2558-2560
2. Rossi GP, Di Bello V, Ganzaroli C, et al. Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension. 2002 ; 40: 23-27
3. Rossi GP, Sechi LA, Giacchetti G, et al. Primary aldosteronism: Cardiovascular, renal and metabolic implications. Trends Endocrinol Metab. 2008 ; 19: 88-90
4. Calhoun DA. Aldosteronism and hypertension. Clin J Am Soc Nephrol. 2006 ; 1: 1039-1045
5. Tsuchiya K, Yoshimoto T, Hirata Y. Endothelial dysfunction is related to aldosterone excess and raised blood pressure. Endocr J. 2009 ; 56: 553-559
6. Hannemann A, Wallaschofski H, Ludemann J, et al. Plasma aldosterone levels and aldosterone-to-renin ratios are associated with endothelial dysfunction in young to middle-aged subjects. Atherosclerosis. 2011 ; 219: 875-879
7. Leibovitz E, Ebrahimian T, Paradis P, et al. Aldosterone induces arterial stiffness in absence of oxidative stress and endothelial dysfunction. J Hypertens. 2009 ; 27: 2192-2200
8. Lin YH, Lin LY, Chen A, et al. Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma. Atherosclerosis. 2012 ; 221: 154-159
9. Coca SG, Perazella MA, Buller GK. The cardiovascular implications of hypokalemia. Am J Kidney Dis. 2005 ; 45: 233-247
10. Born-Frontsberg E, Reincke M, Rump LC, et al. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: Results of the German Conn's Registry. J Clin Endocrinol Metab. 2009 ; 94: 1125-1130
11. Lin YH, Wang SM, Wu VC, et al. The association of serum potassium level with left ventricular mass in patients with primary aldosteronism. Eur J Clin Invest. 2011 ; 41: 743-750
12. Thijssen DH, Black MA, Pyke KE, et al. Assessment of flow-mediated dilation in humans: A methodological and physiological guideline. Am J Physiol Heart Circ Physiol. 2011 ; 300: H2 - H12
13. Bots ML, Westerink J, Rabelink TJ, et al. Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: Effects of technical aspects of the FMD measurement on the FMD response. Eur Heart J. 2005 ; 26: 363-368
14. Hamburg NM, Benjamin EJ. Assessment of endothelial function using digital pulse amplitude tonometry. Trends Cardiovasc Med. 2009 ; 19: 6-11
15. Aizer J, Karlson EW, Chibnik LB, et al. A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus. Lupus. 2009 ; 18: 235-242
16. Hamburg NM, Palmisano J, Larson MG, et al. Relation of brachial and digital measures of vascular function in the community: The Framingham heart study. Hypertension. 2011 ; 57: 390-396
17. Lee CR, Bass A, Ellis K, et al. Relation between digital peripheral arterial tonometry and brachial artery ultrasound measures of vascular function in patients with coronary artery disease and in healthy volunteers. Am J Cardiol. 2012 ; 109: 651-657
18. Lin YH, Huang KH, Lee JK, et al. Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy. J Renin Angiotensin Aldosterone Syst. 2011 ; 12: 48-53
19. Lin YH, Lee HH, Liu KL, et al. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy. Surgery. 2011 ; 150: 526-533
20. Lin YH, Wu XM, Lee HH, et al. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism. J Hypertens. 2012 ; 30: 1606-1613
21. Kuo CC, Wu VC, Huang KH, et al. Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group). J Renin Angiotensin Aldosterone Syst. 2011 ; 12: 348-357
22. Kuo CC, Wu VC, Tsai CW, et al. Combining body mass index and serum potassium to urine potassium clearance ratio is an alternative method to predict primary aldosteronism. Clin Chim Acta. 2011 ; 412: 1637-1642
23. Wu VC, Yang SY, Lin JW, et al. Kidney impairment in primary aldosteronism. Clin Chim Acta. 2011 ; 412: 1319-1325
24. Wu VC, Kuo CC, Wang SM, et al. Primary aldosteronism: Changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment. J Hypertens. 2011 ; 29: 1778-1786
25. Wu VC, Lo SC, Chen YL, et al. Endothelial progenitor cells in primary aldosteronism: A biomarker of severity for aldosterone vasculopathy and prognosis. J Clin Endocrinol Metab. 2011 ; 96: 3175-3183
26. Lin YH, Wang SM, Wu VC, et al. The association of serum potassium level with left ventricular mass in patients with primary aldosteronism. Eur J Clin Invest. 2011 ; 41: 743-750
27. Kuo CC, Wu VC, Huang KH, et al. Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group). J Renin Angiotensin Aldosterone Syst. 2011 ; 12: 348-357
28. Wu VC, Chang HW, Liu KL, et al. Primary aldosteronism: Diagnostic accuracy of the losartan and captopril tests. Am J Hypertens. 2009 ; 22: 821-827
29. Wu VC, Yang SY, Lin JW, et al. Kidney impairment in primary aldosteronism. Clin Chim Acta. 2011 ; 412: 1319-1325
30. Yen RF, Wu VC, Liu KL, et al. 131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results. J Nucl Med. 2009 ; 50: 1631-1637
31. Lin YH, Ho YL, Lee JK, et al. Plasma leptin levels and digital pulse volume in obese patients without metabolic syndrome-a pilot study. Clin Chim Acta. 2011 ; 412: 730-734
32. Hodes RJ, Lakatta EG, McNeil CT. Another modifiable risk factor for cardiovascular disease? Some evidence points to arterial stiffness. J Am Geriatr Soc. 1995 ; 43: 581-582
33. Mahmud A, Feely J. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension. Am J Hypertens. 2005 ; 18: 50-55
34. Safar ME, Avolio A. Aldosterone antagonism and arterial stiffness. Hypertension. 2004 ; 43: e3
35. Lin YH, Lin LY, Chen A, et al. Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma. Atherosclerosis. 2012 ; 221: 154-159
36. Lin YH, Wu XM, Lee HH, et al. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism. J Hypertens. 2012 ; 30: 1606-1613
37. Kato Y, Kurisu S, Mitsuba N, et al. Effects of hypokalemia and left ventricular hypertrophy on QT interval in patients with primary aldosteronism. Int J Cardiol. 2011 ; 152: 380-381
38. Xie Z, Liu J, Malhotra D, et al. Effects of hypokalemia on cardiac growth. Ren Fail. 2000 ; 22: 561-572
39. Bauersachs J. Aldosterone antagonism in heart failure: Improvement of cardiac remodelling, endothelial dysfunction and platelet activation. Eur J Clin Invest. 2004 ; 34: 649-652
40. Schnabel RB, Schulz A, Wild PS, et al. Noninvasive vascular function measurement in the community: Cross-sectional relations and comparison of methods. Circ Cardiovasc Imaging. 2011 ; 4: 371-380